Red wine inhibits monocyte chemotactic protein-1 expression and modestly reduces neointimal hyperplasia after balloon injury in cholesterol-fed rabbits

Circulation

Volumn 100, Issue 22, 1999, Pages 2254-2259

  Feng, An Ning ^a   Chen, Yuh Lien ^b   Chen, Ya Ting ^a   Ding, Yaw Zon ^a   Lin, Shing Jong ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Alcohol; Antioxidants; Proteins; Restenosis; Vessels

Indexed keywords

CHOLESTEROL; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ABDOMINAL AORTA; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIETARY INTAKE; FAT INTAKE; ISCHEMIC HEART DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RESTENOSIS; SWINE; TRANSLUMINAL CORONARY ANGIOPLASTY; WINE;

EID: 0032729718     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.22.2254     Document Type: Article

References (34)

1. Rimm EB, Giovannucci EL, Willett WC, Colditz GA, Ascherio A, Rosner B, Stampfer MJ. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 1991;338:464-468.
2. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992;339:1523-1526.
3. Gaziano JM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, Van Denburgh M, Willett W, Hennekens CH. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 1993;329: 1829-1834.
4. Camargo CA, Hennekens CH, Gaziano M, Glynn RJ, Manson JE, Stampfer MJ. Prospective study of moderate alcohol consumption and mortality in US male physicians. Arch Intern Med. 1997;157:79-85.
5. Fuchs CS, Stampfer MJ, Colditz GA, Giovannucci EL, Manson JE, Kawachi I, Hunter DJ, Hankinson SE, Hennekens CH, Rosner B, Speizer FE, Willett W. Alcohol consumption and mortality among women. N Engl J Med. 1995;332:1245-1250.
6. Stampfer MJ, Colditz GA, Willett W, Speizer FE, Hennekens CH. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med. 1988;319:267-273.
7. Steinberg D, Pearson TA, Kuller LH. Alcohol and atherosclerosis. Ann Intern Med. 1991;114:967-976.
8. Friedman LA, Kimball AW. Coronary heart disease mortality and alcohol consumption in Framingham. Am J Epidemiol. 1986;124:481-489.
9. Ducimetiere P, Guize L, Marciniak A, Milon H, Richard J, Rufat P, for the CORALI Study Group. Arteriographically documented coronary artery disease and alcohol consumption in French men: the CORALI Study. Eur Heart J. 1993;14:727-733.
10. Demrow HS, Slane PR, Folts JD. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation. 1995;91:1182-1188.
11. Fuhrman B, Lavy A, Aviram M. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am J Clin Nutr. 1995;61:549-554.
12. Frankel EN. Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet. 1993;341:454-457.
13. Klatsky AL, Armstrong MA. Alcoholic beverage choice and risk of coronary artery disease mortality: do red wine drinkers fare best? Am J Cardiol. 1993;71:467-469.
14. Whitehead TP, Robinson D, Allaway S, Syms J, Hale A. Effect of red wine ingestion on the antioxidant capacity of serum. Clin Chem. 1995; 41:32-35.
15. de Whalley CV, Rankin SM, Hoult JRS, Jessup W, Leake DS. Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem Pharmacol. 1990;39:1743-1750.
16. Landau C, Lange RA, Hillis LD. Percutaneous transluminal coronary angioplasty. N Engl J Med. 1994;330:981-993.
17. Libby P, Ganz P. Restenosis revisited: new targets, new therapies. N Engl J Med. 1997;337:418-419.
18. Liu MW, Roubin GS, King SB III. Restenosis following coronary angioplasty: potential biological determinants and role of intimal hyperplasia. Circulation. 1989;79:1374-1387.
19. Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerotic heart disease. N Engl J Med. 1997;337:408-416.
20. Ferns GAA, Forster L, Stewart-Lee A, Konneh M, Nourooz-Zadeh J, Anggard EE. Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit. Proc Natl Acad Sci U S A. 1992;89:11312-11316.
21. Freyschuss A, Stiko-Rahm A, Swedenborg J, Henriksson P, Bjorkhem I, Berglund L, Nilsson J. Antioxidant treatment inhibits the development of intimai thickening after balloon injury of the aorta in hypercholesterolemic rabbits. J Clin Invest. 1993;91:1282-1288.
22. Konneh MK, Rutherford C, Li SR, Anggard EE, Ferns GAA. Vitamm E inhibits the intimal response to balloon catheter injury in the carotid artery of the cholesterol-fed rat. Atherosclerosis. 1995;113:29-39.
23. Liu MW, Lin SJ, Chen YL. Local alcohol delivery may reduce phenotype conversion of smooth muscle cells and neointimal formation in rabbit iliac arteries after balloon injury. Atherosclerosis. 1996;127:221-227.
24. Liu MW, Anderson PG, Luo JF, Roubin GS. Local delivery of ethanol inhibits intimal hyperplasia in pig coronary arteries after balloon injury. Circulation. 1997;96:2295-2301.
25. Merritt R, Guruge BL, Miller DD, Chitman BR, Bora PS. Moderate alcohol feeding attenuates postinjury vascular cell proliferation in rabbit angioplasty model. J Cardiovasc Pharmacol. 1997;30:19-25.
26. Yla-Herttuala S, Lipton BA, Rosenfeld ME, Sarkioja T, Yoshimura T, Leonard EJ, Witztum JL, Steinberg D. Expression of monocyte chemoattractan, protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A. 1991;88:5252-5256.
27. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979;18:5294-5299.
28. Alwine JC, Kemp DJ, Stark GR. Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes. Proc Natl Acad Sci U S A. 1977;74: 5350-5354.
29. Pang JHS, Jiang MJ, Chen YL, Wang FW, Wang DL, Chu SH, Chau LY. Increased ferritin gene expression in atherosclerotic lesions. J Clin Invest. 1996;97:2204-2212.
30. Sharpe PC, McGrath LT, McClean E, Young IS, Archbold GPR. Effect of red wine consumption on lipoprotein (a) and other risk factors for atherosclerosis. QJM. 1995;88:101-108.
31. Kondo K, Matsumoto A, Kurata H, Tanahashi H, Koda H, Amachi T, Itakura H. Inhibition of oxidation of low-density lipoprotein with red wine. Lancet. 1994;344:1152. Letter.
32. Robak J, Gryglewski RJ. Flavonoids are scavengers of superoxide anions. Biochem Pharmacol. 1988;37:837-841.
33. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 1993;342:1007-1011.
34. Tardif JC, Cote G, Lesperance J, Bourassa M, Lambert J, Doucet S, Bilodeau L, Nattel S, de Guise P, for the Multivitamins and Probucol Study Group Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med. 1997;337:365-372.